Trial
NCT00394147
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Fox Chase Cancer Center
Collaborators
Eli Lilly and Company
Condition
Head and Neck Cancer
Intervention
pemetrexed
Why stopped
stopped for lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-05